<DOC>
	<DOCNO>NCT01558947</DOCNO>
	<brief_summary>The purpose study evaluate safety effect perioperative chemotherapy treatment advance gastric cancer .</brief_summary>
	<brief_title>Peri-operative Chemotherapy With ECX XP Treatment Advanced Gastric Cancer</brief_title>
	<detailed_description>To evaluate security relapse-free survival time/rate ( 1,2,3 yr ) perioperative chemotherapy ECX ( epirubicin + cisplatin + capecitabine ) XP ( capecitabine + cisplatin）in advance gastric cancer</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>Male female age 18 70 year old . The preoperative evaluation : gastric cancer patient , ≥ T2 N + ; stag II , IIIA , IIIB . Karnofsky score ≥ 70 , life expectancy &gt; 6 month . Endoscopic biopsy diagnosis gastric cancer , exclude nonHodgkin 's lymphoma , leiomyosarcoma mesenchymal tumor . blood biochemical indicator subject must meet following criterion : Hb ≥ 9 g / dl ; WBC ≥ 4,000 / mm3 , ≤ 12000 / mm3 ; PLT ≥ 100,000/mm3 ; GOT , GPT within twice institutional limit , serum total bilirubin &lt; 1.5 time upper limit normal , serum creatinine &lt; 1.25 time upper limit normal creatinine clearance rate ≥ 60ml/min , LVEF ≥ 60 % . receive prior chemotherapy , radiotherapy biological therapy . sign informed consent . must accept standard D2 D2 + radical gastrectomy . good compliance . pregnancy , breastfeed woman . allergy chemotherapy drug metabolic disorder . history organ transplant ( include bone marrow transplantation autologous peripheral stem cell transplantation ) . long received systemic steroid treatment ( Note : shortterm user withdrawal &gt; 2 week select . ) The existence peripheral nervous system disorder significant neurological disorder history central nervous system disorder . patient severe infection require treatment . patient associated dysphagia , active peptic ulcer , incompleteness intestinal obstruction , active gastrointestinal bleeding , perforation . severe liver disease ( cirrhosis ) , kidney disease , respiratory disease uncontrollable diabetes . malignancy cure . EKG abnormalities heart disease apparent clinical symptom , include congestive heart failure , coronary heart disease symptom , uncontrollable arrhythmia , hypertension , heart attack within 12 month III IV grade myocardial infarction . Coronary heart disease symptom , uncontrollable arrhythmia , hypertension , heart attack within 12 month III IV grade myocardial infarction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>Peri-operative chemotherapy</keyword>
</DOC>